Skip to main content
. 2020 Dec 8;222(2):402–407. doi: 10.1016/j.amjsurg.2020.11.048

Table 1.

Patient demographics in the unadjusted cohort and inverse probability weighted cohort.

Unadjusted Cohort
p IPW Adjusted Cohort
p
14–30 days
31–90 days
14–30 days
31–90 days
N = 63,568 (59%) N = 44,206 (41%) Na = 63,607 (59%) Na = 44,157 (41%)
Age, mean (SD) 70.3 (11.6) 71.4 (11.4) <0.001 70.8 (11.4) 70.8 (11.6) 0.69
Female sex 52.4 51.3 0.001 51.9 51.9 0.97
Race <0.001 1.00
White 87.9 84.2 86.4 86.4
Black 8.3 11.6 9.7 9.7
Native American 0.2 0.3 0.2 0.2
East Asian or Polynesian 2 2.2 2.1 2.1
South Asian 0.2 0.3 0.3 0.3
Other or Unknown 1.3 1.4 1.3 1.3
Ethnicity <0.001 0.99
Not Hispanic 89.8 88.8 89.4 89.4
Hispanic 3.5 5 4.1 4.1
Unknown 6.7 6.2 6.5 6.4
Median Income <0.001 0.99
Quartile 1 15.9 17.5 16.5 16.6
Quartile 2 24.2 23.3 23.7 23.7
Quartile 3 27.3 27.1 27.2 27.2
Quartile 4 32.7 32.2 32.5 32.5
HS Diploma Attainment <0.001 1.00
Quartile 1 14.3 16.8 15.3 15.3
Quartile 2 25.2 26.1 25.5 25.5
Quartile 3 34.7 34.1 34.5 34.5
Quartile 4 25.9 23 24.7 24.7
Charlson/Deyo Score <0.001 1.00
0 68.6 63.5 66.5 66.4
1 23.5 25.8 24.5 24.5
2 5.9 7.7 6.7 6.7
3+ 1.9 3 2.4 2.4
Distance to Facility 0.001 0.88
<20 mi 79.4 78.6 79.1 79.1
>20 mi 20.6 21.4 20.9 20.9
Insurance type <0.001 0.99
No Insurance 1.4 1.7 1.5 1.5
Private Insurance 31.8 27.4 30 29.9
Government Healthcare Plan 65.5 69.3 67.1 67.2
Unknown 1.3 1.6 1.4 1.4
NCDB Stage <0.001 0.84
Stage I (T1/2, N0) 43.8 49.9 46.3 46.4
Stage II (T3, N0) 56.2 50.1 53.7 53.6
Facility type <0.001 1.00
Community Cancer Center 12.9 10.8 12 11.9
Comprehensive Cancer Center 51.2 44.9 48.7 48.7
Academic/Research Cancer Center 25.6 32.6 28.4 28.5
Integrated Network Cancer Program 10.3 11.7 10.9 10.9
Adjuvant chemo <0.001 0.94
No 87.6 90.5 88.8 88.8
Yes 8.3 5.4 7.1 7.1
Unknown 4.1 4.1 4.1 4.1
a

Inverse probability of treatment weight-adjusted.